We are pleased to announce the publication of “Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis” in the International Journal of Environmental Research and Public Health. This contributes to the growing body of evidence supporting scale up on the Bill & Melinda Gates Foundation-funded, Wisepill Technologies-developed evriMED digital medication monitor. The newly published manuscript summarizes the approach and results of a formal usability evaluation that was conducted by the China CDC and represents a best practice in implementation science regarding adherence technologies. The evaluation sought to understand MERM user performance, satisfaction, and acceptability to both TB patients and TB providers in a rural setting in China.
“The patients themselves reported that the MERM was easy to use and improved their adherence and their experience of taking their medications, thereby enhancing their quality of life and that of their families. The medical staff also reported that it reduced the workload and increased their job satisfaction.”
Additional studies are underway in China evaluating the impact of these adherence technologies on patient adherence (including persistence) and evaluating whether and to what extent improving adherence is related to better health outcomes for patients.